Biomoduline T effect in upper respiratory infections and geriatric patients polypharmacy

Marlene García Orihuela; Vladimir Capdevila; René Suárez Martínez; Liliam Rodríguez Rivera; Inés Castro González

2014, Number 3

<< Back Next >>

Revista Habanera de Ciencias Médicas 2014; 13 (3)

Biomoduline T effect in upper respiratory infections and geriatric patients' polypharmacy

García OM, Capdevila V, Suárez MR, Rodríguez RL, Castro GI

Full text

How to cite this article

Language: Spanish
References: 23
Page: 425-436
PDF size: 143.04 Kb.

ABSTRACT

Introduction: Biomoduline T (BM T) is a natural medication composed by Thyroid hormones that are natural polypeptides. These hormones are obtained by an original method that has an immunomodulator effect, characterized by the induction of the differentiation of T lymphocytes, the lack of toxicity, not producing neither alterations in organs or tissues, nor negative interference in the functions of the fundamental systems.
Objective: aging and Health with the aim of evaluating the effect of homeopathic presentation of Biomoduline T in upper respiratory infections and the polypharmacy in geriatric patients.
Material and Method: a controlled open and randomized clinical trial, phase II was performed during 2008 and 2009 at the Research Center on Longevity. One hundred patients previously given their informed consent were included in the trial. They were divided into two groups; one received the study treatment and the other the control treatment. The primary response in patients following the control treatment was the incidence and severity of respiratory infection during and after the treatment. The statistical package version 3.1 Epidat was used.
Results: the age average was between 70 and 79 years old, 41,3% in the cases and 49,0% in the controls. The female sex predominated in both groups, (54,4% y 53,1% respectively). The flu prevalence decreased at the end of the treatment to 45,7% in the cases group and to 39,8% in the control group. There were fewer drugs intake at the end of each stage. Only five medications were taken by the 19,6% of the cases and the 16,3% of the controls.
Conclusions: the pharmaceutical presentation of Biomoduline T had a good therapeutic effect in the reduction of upper respiratory infections, decreasing hospital admissions for this cause, and drugs intake.

REFERENCES

Oficina Nacional de Estadísticas-Centro de Estudios de Población y Desarrollo 2010. Envejecimiento, Políticas Públicas y Desarrollo en América Latina. Retos presentes, necesidades futuras. La Habana,Cuba.
Jairo A, Cerón C. Inmunosenescencia. En: Jorge Hernán López Ramírez. Carlos Alberto Cano Gutiérrez. José Fernando Gómez Montes, editores. Fundamentos de Medicina, Geriatría. Medellín: Corporación para investigaciones biológicas; 2006, p. 487-489.
Burns EA, Goodwin JS. Immunology of Aging. In: Christine K. Cassel, Rosanne M. Leipzig, editors. Geriatric Medicine An Evidence-Based Approach. New York: Springer; 2006, p. 783-800.
Sakata _Kaneko S, Wakatsuki Y, Matsunaga Y, Usui T, Kita T. Altered Th1/Th2 commitment in human CD4+ T cells with aging. Clinical and Experimental Imnunology. 2000;120:267-273.
Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. ClinInterv Aging. 2008;3:383-9.
Laporte JR, Capella D. Mecanismo de producción y diagnóstico clínico de los efectos indeseables producidos por medicamentos. En: Laporte JR, Tognoni G. Principios de Epidemiología del medicamento. 2da. Ed. Barcelona:Masson- Salvat;1993, p.95-106.
Salvador J, Adams EJ, Ershler R, Ershler WB. Futures challages in analysis and treatment of human immune senescence. Immunol Allerg Clin N Amer. 2003;23:133-148.
Ríos M, FommellI Cruz M. "Algunos aspectos de la inmunofarmacología de la Biomodulina T". Congreso de la Sociedad Cubana de Ciencias Farmacéuticas, 5. La Habana: 17 de abril de 1993.
Alfonso HA. "Estudio toxicológico de Biomodulina T". Centro Nacional de Sanidad Agropecuaria. Informe de Ensayos Preclínicos presentado al CECMED, La Habana: 1993.
Devesa E, García R, Rodríguez R. La Biomodulina T como inmunomodulador en Geriatría. Ensayo clínico controlado, Fase II. La Habana: 1994.
Linde K, Clausius N, Ramírez G. Are the clinical effects of homeopathy placebo effects? A metaanalysis of placebo-controlled trials. Lancet.1997 Sept 20;350:834- 834.
Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A. Montelukast as addon therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax. 2007;63:453-62.
Morón Rodríguez F, Levy Rodríguez M. Farmacología General. En: Fundamentos de los Ensayos Clínicos. La Habana: ECIMED; 2002, p. 44-54.
Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011. (Consultado septiembre 2013). Disponible en: http://www.goldcopd.org
Biomodulina, un producto que se encarga de llevar el sistema inmunológico a niveles normales. Nov. 2003. (Acceso 27 Sept 2007). Disponible en: http://www.imss.gob.mx/NR/rdonlyres
Thomas T. Yoshikawa. Infectious Diseases. In: Christine K. Cassel, Rosanne M. Leipzig, editors. Geriatric Medicine An Evidence-Based Approach. New York: Springer; 2006, p. 801-817.
Blázquez JL, Blanco JA, Sánchez A. EPOC Reagudizado. En: Julián Jiménez A, editor. Manual de Protocolos y Actuación. Urgencias. 2da. ed. Toledo: Complejo Hospitalario de Toledo; 2004, p.319-25.
Hutchison BG, Oxman AD, Shannon HS, Lloyd S, Altmayer CA, Thomas K. Clinical effectiveness of pneumococcal vaccine: meta-analysis. Comentarios en: The Cochrane Labrary. Issue 3, 2002.
García Orihuela M, Suárez Martínez R, Sánchez ME. Comorbilidad, estado funcional y terapéutica farmacológica en pacientes geriátricos. Revista Cubana de Medicina General Integral. Editorial Ciencias Médicas. Octubre-diciembre, 2012; 28(4). (Consultado agosto 2013). Disponible en: http://bvs.sld.cu/revistas/mgi/vol28_4_12/mgisu412.htm
The National Institute for Clinical Excellence (NICE). Respiratory tractinfectionsantibiotic prescribing. NICE clinical guideline 69. (Consultado agosto 2013). Disponible en: http://guidance.nice.
Smucny J, Fahey T, Becker L, Glazier R. Antibióticos para la bronquitis aguda (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 4. Oxford: Update Software Ltd.. (Traducida de The Cochrane Library, 2008 Issue 3. Chichester, UK: John Wiley &Sons, Ltd.).(Consultado septiembre 2013). Disponible en: http://www.update-software.com
Shehab N, Patel PR, Srinivasan, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008; 47: 735-743.
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT: Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007; 370:173-84.